company

Cellular Intelligence

Boston-based biotechnology company founded in 2023 that is building AI models of cell behaviour for cell-therapy development. It was called Somite AI until January 2026.

Known aliases

Somite AI
Somite.ai

Relationships

No evidence-backed relationships are recorded.

Current clusters

invest2 publishers

Novo Nordisk took equity in the buyer of the Parkinson's therapy it shelved

Cellular Intelligence has added Bob Langer and Yann LeCun to its scientific advisory board. The $62m to $70m it has raised now has to take STEM-PD, the cell therapy Novo Nordisk dropped, through Phase 2.

Publishers:cryptobriefing.comfortune.com

Reality

Evidence45
Adoption32
Hype gap+38
Incentives72
Confidence58